Back to ACAD
VANGUARD GROUP INC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
20
Latest value
$1.4M
Q4 2025
Peak value
$377M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $415K |
| Q1 2025 | $1.6M |
| Q1 2025 | $1.9M |
| Q1 2025 | $247.8M |
| Q1 2025 | $803K |
| Q2 2025 | $540K |
| Q2 2025 | $2.1M |
| Q2 2025 | $2.6M |
| Q2 2025 | $322.9M |
| Q2 2025 | $1M |
| Q3 2025 | $17.5M |
| Q3 2025 | $2.1M |
| Q3 2025 | $1M |
| Q3 2025 | $612K |
| Q3 2025 | $302.7M |
| Q4 2025 | $766K |
| Q4 2025 | $2.6M |
| Q4 2025 | $23M |
| Q4 2025 | $377M |
| Q4 2025 | $1.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $1.4M | 53.2K | — | — |
| Q4 2025 | $377M | 14.11M | — | — |
| Q4 2025 | $23M | 859.8K | — | — |
| Q4 2025 | $2.6M | 99.0K | — | — |
| Q4 2025 | $766K | 28.7K | — | — |
| Q3 2025 | $302.7M | 14.19M | — | — |
| Q3 2025 | $612K | 28.7K | — | — |
| Q3 2025 | $1M | 48.5K | — | — |
| Q3 2025 | $2.1M | 97.8K | — | — |
| Q3 2025 | $17.5M | 819.3K | — | — |
| Q2 2025 | $1M | 48.5K | — | — |
| Q2 2025 | $322.9M | 14.97M | — | — |
| Q2 2025 | $2.6M | 121.1K | — | — |
| Q2 2025 | $2.1M | 99.4K | — | — |
| Q2 2025 | $540K | 25.0K | — | — |
| Q1 2025 | $803K | 48.3K | — | — |
| Q1 2025 | $247.8M | 14.92M | — | — |
| Q1 2025 | $1.9M | 113.8K | — | — |
| Q1 2025 | $1.6M | 97.0K | — | — |
| Q1 2025 | $415K | 25.0K | — | — |
Other funds holding ACAD
$229.6M
$229.6M
$211.3M
$202.4M
$185.5M
$154.8M